Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Addict Behav ; 115: 106771, 2021 04.
Artigo em Inglês | MEDLINE | ID: mdl-33387975

RESUMO

PURPOSE: Past 30-day tobacco and marijuana use commonly occur among adolescents. It is unclear whether use of one product precedes the other, especially given the new climate surrounding marijuana legalization and the increasing popularity of e-cigarettes. METHODS: Six-panel cross-lagged regression models, with six months between each panel/Wave (2014-17), were used to model stability paths, bi-directional paths, and comorbid paths (i.e., correlations) between past 30-day use of marijuana and tobacco products. Data were derived from three cohorts of adolescents (n = 3907; weighted N = 461,069) in 6th, 8th, and 10th grades at baseline. RESULTS: Few bidirectional relationships between past 30-day tobacco and marijuana use were observed in early adolescence (6th grade). During the middle adolescence developmental period (8th grade), past 30-day marijuana use was prospectively associated with greater risk of past 30-day tobacco use. In late adolescence (10th grade), increased odds of past 30-day marijuana use given prior past 30-day e-cigarette use, and vice versa, were observed. For all cohorts, stability paths were common, especially for past 30-day marijuana use. Comorbid use was common in middle adolescence (8th grade) but small in magnitude. CONCLUSIONS: This is the first study to longitudinally situate comorbid, past 30-day use of tobacco and marijuana and simultaneously examine bi-directional past 30-day use of these products for adolescents. Marijuana use more often and more strongly predicted subsequent tobacco use than the reverse, especially during middle adolescence (13-15 years old). Marijuana use should be considered when creating interventions that address adolescent e-cigarette use in the U.S.


Assuntos
Comportamento do Adolescente , Sistemas Eletrônicos de Liberação de Nicotina , Uso da Maconha , Produtos do Tabaco , Adolescente , Humanos , Uso da Maconha/epidemiologia , Texas/epidemiologia , Nicotiana , Uso de Tabaco
2.
J Adolesc Health ; 68(1): 116-122, 2021 01.
Artigo em Inglês | MEDLINE | ID: mdl-32631731

RESUMO

PURPOSE: Prevalence of past 30-day tobacco and marijuana use are highest among young adults in the U.S., and comorbid use of these products is common. However, it is unclear whether the use of one product precedes the other-an important consideration, given the new climate surrounding marijuana legalization and the popularity of e-cigarette products. METHODS: Six-panel cross-lagged regression models, with 6 months between each panel/wave, were used to model bidirectional paths between past 30-day use and comorbid use of marijuana and tobacco products from 2014 to 2017 among young adults (N = 5,221 college students, aged 18-25 years). RESULTS: Combustible tobacco use and e-cigarette use were prospectively associated with greater risk of future marijuana use while controlling for the stability of use over time, age, race/ethnicity, and sex. Marijuana use was prospectively associated with greater risk of future combustible tobacco and e-cigarette use. Comorbid use was common, but while the odds of comorbid use decreased with increasing age, odds of tobacco use increased. CONCLUSIONS: More young adults may be consolidating their use than are successfully ceasing their tobacco or marijuana use as they mature through young adulthood. Although we observed decreases in comorbid use of combustible tobacco with marijuana and e-cigarettes with marijuana, we simultaneously observed strong stability in single use of these products over time. Taken together, these results should help structure interventions specific to young adults that target use and comorbid use in early young adulthood to discourage initiation, encourage cessation, and curb subsequent escalation in later young adulthood.


Assuntos
Sistemas Eletrônicos de Liberação de Nicotina , Uso da Maconha , Produtos do Tabaco , Adolescente , Adulto , Humanos , Uso da Maconha/epidemiologia , Texas/epidemiologia , Nicotiana , Uso de Tabaco/epidemiologia , Adulto Jovem
3.
Glob Health Promot ; 27(2): 63-73, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-30943128

RESUMO

PURPOSE: ¡Activate Ya! was a group-randomized controlled intervention trial aimed at developing and evaluating the impact of a school-based intervention on preventing cigarette smoking and promoting physical activity (PA) in secondary school students in Uruguay. Secondary aims were to evaluate the program's impact on students' smoking- and PA-related psychosocial risk and protective factors. METHODS: Sixteen schools and n = 654 students participated in the study. The one-year intervention included a classroom-based curriculum, an afterschool program, activity breaks, and final showcase event. A self-administered questionnaire measured outcomes at three time points. Fixed effects regression models tested for differences in outcomes by study condition. RESULTS: While positive intervention effects were found for selected psychosocial-related smoking outcomes, no impact on past-year smoking or smoking susceptibility was detected. Past 7-day PA, measured by the PAQ-C, was significantly higher among intervention school students overall (p = .048) and for girls (p = .03) at posttest, and intervention girls reported significantly higher athletic identity PA competence, friend and teacher PA support at posttest, and PA enjoyment at follow-up (p < .05). CONCLUSION: The positive short-term effects of ¡Activate Ya! on PA and related outcomes for girls support the utility of school-based health promotion in Uruguay. Additional research is needed to determine the most effective strategies to prevent tobacco use among students and promote PA among boys in this setting.


Assuntos
Exercício Físico/fisiologia , Nicotiana/efeitos adversos , Serviços de Saúde Escolar/estatística & dados numéricos , Instituições Acadêmicas/organização & administração , Prevenção do Hábito de Fumar/métodos , Adolescente , Criança , Feminino , Comportamentos Relacionados com a Saúde/fisiologia , Humanos , Aprendizagem , Masculino , Fumar/psicologia , Esportes/estatística & dados numéricos , Estudantes/psicologia , Uruguai/epidemiologia
4.
Addict Behav ; 91: 68-74, 2019 04.
Artigo em Inglês | MEDLINE | ID: mdl-30241775

RESUMO

The primary objective of this study was to identify risk factors associated with becoming susceptible to e-cigarette use over the course of a year among e-cigarette-naive adolescents considering a comprehensive model of risk factors (risk perceptions, social influences and norms, affective risk factors, and other behavioral risk factors). Data came from the Texas Adolescent Tobacco and Marketing Surveillance system (TATAMS), a longitudinal cohort study of students who were in the 6th, 8th, and 10th grades (n = 3907) during the 2014-2015 academic year. Weighted generalized linear mixed models assessed multiple predictors' associated with the transition to susceptibility to e-cigarettes at 12 months. Among 6th graders, family influence, use of other substances, and positive affect were important. Adolescents transitioning from 8th grade to high school presented the greatest number of risk factors (e.g., social and normative influences). Only sensation seeking increased the risk of susceptibility to e-cigarettes among 10th graders. Overall, by grade level, incidence of susceptibility to e-cigarettes at 12 months did not vary, but risk factor profiles varied substantially.


Assuntos
Atitude Frente a Saúde , Família , Influência dos Pares , Meio Social , Normas Sociais , Vaping/epidemiologia , Adolescente , Comportamento do Adolescente , Desenvolvimento do Adolescente , Criança , Estudos de Coortes , Feminino , Humanos , Modelos Lineares , Estudos Longitudinais , Masculino , Fatores de Risco , Consumo de Álcool por Menores/estatística & dados numéricos , Estados Unidos/epidemiologia
5.
J Pediatric Infect Dis Soc ; 8(5): 414-421, 2019 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-30184153

RESUMO

BACKGROUND: The rotavirus disease burden has declined substantially since rotavirus vaccine was introduced in the United States in 2006. The aim of this study was to determine the viral etiology of acute gastroenteritis (AGE) in US children aged <2 years. METHODS: The New Vaccine Surveillance Network (NVSN) of geographically diverse US sites conducts active pediatric population-based surveillance in hospitals and emergency departments. Stool samples were collected from children aged <2 years with symptoms of AGE (n = 330) and age-matched healthy controls (HCs) (n = 272) between January and December 2012. Samples were tested by real-time reverse-transcriptase polymerase chain reaction assays {adenovirus (type 40 and 41), norovirus, parechovirus A, enterovirus, sapovirus, and astrovirus} and an enzyme immunoassay (rotavirus). All samples that tested positive were genotyped. RESULTS: Detection rates of pathogens in children with AGE versus those of HCs were, respectively, 23.0% versus 6.6% for norovirus (P < .01), 23.0% versus 16.0% for adenovirus (P = .08), 11.0% versus 16.0% for parechovirus A (P = .09), 11.0% versus 9.0% for enterovirus (P = .34), 7.0% versus 3.0% for sapovirus (P = .07), 3.0% versus 0.3% for astrovirus (P = .01), and 3.0% versus 0.4% for rotavirus (P = .01). A high prevalence of adenovirus was detected at 1 surveillance site (49.0% for children with AGE and 43.0% for HCs). Norovirus GII.4 New Orleans was the most frequently detected (33.0%) norovirus genotype. Codetection of >1 virus was more common in children with AGE (16.0%) than in HCs (10.0%) (P = .03). CONCLUSIONS: Norovirus, astrovirus, sapovirus, and rotavirus were detected significantly more in children with AGE than in HCs, and norovirus was the leading AGE-causing pathogen in US children aged <2 years during the year 2012.


Assuntos
Gastroenterite/epidemiologia , Gastroenterite/virologia , Vírus de RNA/patogenicidade , Vacinas contra Rotavirus/administração & dosagem , Doença Aguda , Distribuição por Idade , Estudos de Casos e Controles , Fezes/virologia , Técnicas de Genotipagem , Humanos , Técnicas Imunoenzimáticas , Lactente , Recém-Nascido , Vírus de RNA/genética , Vírus de RNA/isolamento & purificação , Reação em Cadeia da Polimerase em Tempo Real , Fatores de Tempo , Estados Unidos/epidemiologia
6.
J Neurol Sci ; 305(1-2): 149-51, 2011 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-21444094

RESUMO

We describe a fatal case of proven enterovirus 71 meningoencephalitis complicating monoclonal anti-CD20 antibody therapy for non-Hodgkin's lymphoma. B-cell depletion, an effective treatment strategy in an expanding spectrum of hematological and inflammatory disorders, impairs neutralising antibody-mediated clearance of enterovirus. The global threat of emerging neurotropic viruses such as enterovirus 71 is heightened by an increasing pool of susceptible individuals in non-endemic regions.


Assuntos
Anticorpos Monoclonais Murinos/efeitos adversos , Enterovirus Humano A/imunologia , Infecções por Enterovirus/imunologia , Imunossupressores/efeitos adversos , Meningoencefalite/virologia , Antineoplásicos/efeitos adversos , Infecções por Enterovirus/complicações , Evolução Fatal , Humanos , Masculino , Meningoencefalite/fisiopatologia , Pessoa de Meia-Idade , Rituximab
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA